Company Profile
Stereotaxis Stock Price, News & Analysis
- Ticker:
- STXS
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.28 USD (-1.54%)
Close
Last updated: July 28, 2026
193M USD
Market cap
Why the stock is moving
As of Jul 28, 2026, STXS closed down 1.54% at $1.28. No new same-company headline was identified in the current news window.
Company overview
Business overview
Stereotaxis is a medical device company focused on robotic systems for minimally invasive cardiac procedures. Its business is built around surgical navigation and procedure-specific technology.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Stereotaxis sits in surgical robotics and medtech.
Business Model Characteristics
The company depends on system adoption, hospital penetration, and the expansion of robotic cardiac procedures.
Position Within the Biotechnology Landscape
Stereotaxis is a niche surgical-robotics name whose stock is driven by adoption and execution rather than biotech catalysts.
Future catalysts
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.
Recent news
- 01
- 02
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
Source: Stereotaxis
- 03
Stereotaxis Completes Acquisition of Robocath
Source: Stereotaxis
- 04
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
Source: Stereotaxis
- 05
Stereotaxis Announces First MAGiC Procedures in the United States
Source: Stereotaxis
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Stereotaxis (STXS)?
Stereotaxis (STXS) most recently closed at 1.28 USD, a -1.54% move versus the previous session.
What is the market cap of Stereotaxis (STXS)?
Stereotaxis currently has a market capitalization of 193M USD on BioPharmSignal.
What does Stereotaxis do?
Stereotaxis is a medical device company focused on robotic systems for minimally invasive cardiac procedures. Its business is built around surgical navigation and procedure-specific technology.
On which exchange is STXS stock listed?
Stereotaxis (STXS) is associated with AMEX, United States, Biopharma.
What is Stereotaxis?
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow.
Which conditions is Stereotaxis targeting with Stereotaxis?
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow.
How does Stereotaxis describe recent progress with Stereotaxis?
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow.
What future catalysts are investors watching for Stereotaxis?
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.